The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.

MLA

Fratti, R. A., et al. “The Effect of the New Triazole, Voriconazole (UK-109,496), on the Interactions of Candida Albicans and Candida Krusei with Endothelial Cells.” Journal of Chemotherapy (Florence, Italy), vol. 10, no. 1, Feb. 1998, pp. 7–16. EBSCOhost, https://doi.org/10.1179/joc.1998.10.1.7.

APA

Fratti, R. A., Belanger, P. H., Sanati, H., & Ghannoum, M. A. (1998). The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells. Journal of Chemotherapy (Florence, Italy), 10(1), 7–16. https://doi.org/10.1179/joc.1998.10.1.7

Chicago

Fratti, R A, P H Belanger, H Sanati, and M A Ghannoum. 1998. “The Effect of the New Triazole, Voriconazole (UK-109,496), on the Interactions of Candida Albicans and Candida Krusei with Endothelial Cells.” Journal of Chemotherapy (Florence, Italy) 10 (1): 7–16. doi:10.1179/joc.1998.10.1.7.